Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.67 USD | -12.17% | +11.72% | -60.36% |
04-10 | Eiger BioPharmaceuticals, Inc.(NasdaqGM:EIGR) dropped from NASDAQ Composite Index | CI |
04-08 | Eiger BioPharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 25.22M 34.4M | Sales 2025 * | 32.65M 44.54M | Capitalization | 3.95M 5.39M |
---|---|---|---|---|---|
Net income 2024 * | -24M -32.74M | Net income 2025 * | -9M -12.28M | EV / Sales 2024 * | 0.16 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.12 x |
P/E ratio 2024 * |
-0.17
x | P/E ratio 2025 * |
-0.74
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.21% |
Latest transcript on Eiger BioPharmaceuticals, Inc.
1 day | -12.17% | ||
1 week | +11.72% | ||
Current month | -46.65% | ||
1 month | -46.65% | ||
3 months | -54.59% | ||
6 months | -60.44% | ||
Current year | -60.36% |
Managers | Title | Age | Since |
---|---|---|---|
David Apelian
CEO | Chief Executive Officer | 59 | 17-06-13 |
Director of Finance/CFO | 58 | 23-04-12 | |
James Vollins
CMP | Compliance Officer | 55 | 23-04-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 22-07-17 | |
Thomas Dietz
CHM | Chairman | 60 | 16-03-21 |
David Apelian
CEO | Chief Executive Officer | 59 | 17-06-13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.00% | 18 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.67 | -12.17% | 18,908 |
24-04-25 | 3.04 | -19.95% | 17,019 |
24-04-24 | 3.798 | -3.86% | 14,300 |
24-04-23 | 3.95 | -1.25% | 28,020 |
24-04-22 | 4 | +67.36% | 78,021 |
Delayed Quote OTC Markets, April 26, 2024 at 03:59 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.36% | 3.95M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- EIGR Stock